Status: Recruiting
Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
Part 1 : To evaluate the safety of single-dose KK3910 in healthy volunteers. Part 2 : To evaluate the safety of multiple-dose KK3910 in patients with essential hypertension. Part 3 : To assess the safety profile of repeated dosing of KK3910 in an additional hypertension cohort.
Participants needed: 160
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Kyowa Kirin Co., Ltd.Updated: Jul 1, 2026Locations: 3
Eligibility criteria
Voluntary consent to participate in this study must be given (in writing) [+8]
History of any respiratory disease, heart disease, gastrointestinal disease, ren... [+19]